Shilpa Medicare is currently trading at Rs. 671.30, up by 27.65 points or 4.30% from its previous closing of Rs. 643.65 on the BSE.
The scrip opened at Rs. 644.05 and has touched a high and low of Rs. 673.80 and Rs. 642.70 respectively. So far 13887 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 685.00 on 12-Jul-2024 and a 52 week low of Rs. 296.45 on 26-Oct-2023.
Last one week high and low of the scrip stood at Rs. 674.75 and Rs. 615.25 respectively. The current market cap of the company is Rs. 6569.59 crore.
The promoters holding in the company stood at 44.39%, while Institutions and Non-Institutions held 16.69% and 38.92% respectively.
Shilpa Medicare’s 100% subsidiary--Shilpa Pharma Lifesciences has received GMP Certification from COFEPRIS-Mexico for its Active Pharmaceutical Ingredient (API) manufacturing facility, Unit II, situated at Raichur in Karnataka state. The said manufacturing facility had undergone a GMP inspection by COFEPRIS-Mexico from November 6, 2023 to November 10, 2023.
The facility is involved in manufacturing various oncology and nononcology APIs. The company remains commit ted to maintain the GMP status and quality standards as per the expectations and standards of Global Regulatory Authorities.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
